Glutathione peroxidase 1 Pro198Leu variant contributes to the metabolic syndrome in men in a large Japanese cohort

American Journal of Clinical Nutrition

Volumn 87, Issue 6, 2008, Pages 1939-1944

  Kuzuya, Masafumi ^a   Ando, Fujiko ^b   Iguchi, Akihisa ^a   Shimokata, Hiroshi ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE 1; INSULIN; LEUCINE; PROLINE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY FAT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE FREQUENCY; GENOTYPE; HOMEOSTASIS; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PANCREAS ISLET CELL FUNCTION; PREVALENCE; PROTEIN POLYMORPHISM; RISK; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

EID: 45749088869     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/87.6.1939     Document Type: Article

References (35)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20.
2. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003;52:1-8.
3. Giugliano D, Ceriello A, Esposito K. Glucose metabolism and hyperglycemia. Am J Clin Nutr 2008;87(suppl):217S-22S.
4. Palmieri VO, Grattagliano I, Portincasa P, Palasciano G. Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr 2006;136:3022-6.
5. Eriksson JW. Metabolic stress in insulin's target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance. FEBS Lett 2007;581:3734-42.
6. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114:1752-61.
7. Jang Y, Lee JH, Cho EY, Chung NS, Topham D, Balderston B. Differences in body fat distribution and antioxidant status in Korean men with cardiovascular disease with or without diabetes. Am J Clin Nutr 2001; 73:68-74.
8. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006;440:944-8.
9. Fridlyand LE, Philipson LH. Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes Metab 2006;8:136-45.
10. Ward NC, Croft KD. Hypertension and oxidative stress. Clin Exp Pharmacol Physiol 2006;33:872-6.
11. Beckett GJ, Arthur JR. Selenium and endocrine systems. J Endocrinol 2005;184:455-65.
12. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med 1999;27:916-21.
13. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004;134:489-92.
14. Ratnasinghe D, Tangrea JA, Andersen MR, et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res 2000;60:6381-3.
15. Hu YJ, Diamond AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 2003;63:3347-51.
16. Hu Y, Benya RV, Carroll RE, Diamond AM. Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer. J Nutr 2005;135(suppl):3021S-4S.
17. Ravn-Haren G, Olsen A, Tjønneland A, et al. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 2006;27:820-5.
18. Hamanishi T, Furuta H, Kato H, et al. Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intimamedia thickness of carotid arteries and risk of macrovascular diseases in japanese type 2 diabetic patients. Diabetes 2004;53:2455-60.
19. Weiss N, Zhang YY, Heydrick S, Bierl C, Loscalzo J. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc Natl Acad Sci U S A 2001;98:12503-8.
20. Kuzuya M, Ando F, Iguchi A, Shimokata H. Preproghrelin Leu72Met variant contributes to overweight in middle-agedmenof a Japanese large cohort. Int J Obes (Lond) 2006;30:1609-14.
21. Kuzuya M, Ando F, Iguchi A, Shimokata H. No association between rs7566605 variant and obesity in Japanese. Obesity (Silver Spring) 2007; 15:2531-4.
22. Shimokata H, Ando F, Niino N. A new comprehensive study on agingthe National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA). J Epidemiol 2000;10(suppl):S1-9.
23. Banauch D, Brummer W, Ebeling W, et al. A glucose dehydrogenase for the determination of glucose concentrations. Z Klin Chem Klin Biochem 1975;13:101-7.
24. Akamura Y, Kuzuya T, Hayashi M, Ide T, Kuzuya N. Immunological reactivity of insulin to sepharose coupled with insulin antibody - its use for the extraction of insulin from serum. Biochem Biophys Res Commun 1970;38:947-53.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
26. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation 1993;88(5 Pt 1):2460-70.
27. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-52.
28. IDF Worldwide Definition of the Metabolic Syndrome. Internet: http:// www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf (accessed 24 August 2005).
29. Raaschou-Nielsen O, Sørensen M, Hansen RD, et al. GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer. Cancer Lett 2007;247:293-300.
30. McCarthy JJ, Meyer J, Moliterno DJ, Newby LK, Rogers WJ, Topol EJ. GenQuest multicenter study. Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. Hum Genet 2003;114:87-98.
31. Freson K, Stolarz K, Aerts R, et al. European Project on Genes in Hypertension Investigators. -391 C to G substitution in the regulator of G-protein signalling-2 promoter increases susceptibility to the metabolic syndrome in white European men: consistency between molecular and epidemiological studies. J Hypertens 2007;25:117-25.
32. Poulsen P, Vaag A, Kyvik K, Beck-Nielsen H. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia 2001;44:537-43.
33. Meirhaeghe A, Helbecque N, Cottel D, Amouyel P. Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population. Int J Obes Relat Metab Disord 2000;24:382-7.
34. Massafra C, Gioia D, De Felice C, Muscettola M, Longini M, Buonocore G. Gender-related differences in erythrocyte glutathione peroxidase activity in healthy subjects. Clin Endocrinol (Oxf) 2002;57:663-7.
35. Ali SS, Xiong C, Lucero J, Behrens MM, Dugan LL, Quick KL. Gender differences in free radical homeostasis during aging: shorter-lived female C57BL6 mice have increased oxidative stress. Aging Cell 2006; 5:565-74.